ERFURT and BERLIN, Germany, June 17th, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028) announces that it has granted incentive stock options to purchase up to 371,000 common shares of the Company to certain directors, officers, employees and consultants in accordance with its stock option plan, including options to purchase up to 100,000 shares to certain directors and officers. Each option vests immediately has an exercise price of $0.50 per share and is exercisable after a hold period of four months from issuance.The options will expire on June 17th, 2021.
AMP also reminds shareholders and investors that it will hold its Annual General Meeting of Shareholders (AGM) on Monday, June 29th, 2020, beginning at 3:00 p.m. Central European Time (6:00 a.m. Pacific Standard Time) to conduct formal business follow by an online question and answer session with AMP’s management.
Questions can be submitted until Thursday, June 25th, 2020 to: email@example.com
About AMP German Cannabis Group Inc.
AMP German Cannabis Group is licensed to import European Union – Good Manufacturing Practice (EU-GMP) medical cannabis and sell to pharmaceutical distributers or pharmacists directly, the only point-of-sale for medical cannabis to German patients.
AMP has entered into a non-exclusive distribution agreement for medical cannabis with a leading distributor of pharmaceuticals products to more than 13,000 pharmacies throughout Germany for monthly shipments starting in the second half of 2020.
AMP will begin importing from the Netherlands, Canada and other countries upon its medical cannabis suppliers receiving German EU-GMP certification.